Clinical Trial Designs for Immunogenicity Assessments

Time: 3:30 pm
day: Day One

Details:

  • Incorporate Immunogenic Adverse Events assessment endpoints in clinical trial protocols and statistical analyses plans
  • Implementing robust systems for collection and medical evaluation of Immunogenic Adverse Events occurring during clinical trials
  • Identifying clinically significant Immunogenic Adverse Events for participants with and without ADA

Speakers: